Quality Assurance of Clinical Trials in the Management of Cancer in the Head and Neck
Thomas J. FitzGerald(University of Massachusetts Chan Medical School), Fran Laurie(University of Massachusetts Chan Medical School), Kenneth Ulin(University of Massachusetts Chan Medical School), M. Giulia Cicchetti(Providence College), Michael V. Knopp(University of California, Los Angeles), Joseph O. Deasy(Memorial Sloan Kettering Cancer Center), Keith S. White(Primary Children's Hospital), Geoffrey S. Ibbott(American Board of Internal Medicine), Sandra Kessel(Calista Therapeutics (United States)), Lawrence H. Schwartz(Memorial Sloan Kettering Cancer Center), Richard Hanusik, Maryann Bishop‐Jodoin(Health Insurance Review and Assessment Service), Joel Saltz(Stony Brook Medicine), Walter Bosch(Washington University in St. Louis), Mitchell D. Schnall(California University of Pennsylvania), James A. Purdy(Roth and Rau (Germany)), Marcia Urie(Providence College), Lester J. Peters(Peter MacCallum Cancer Centre), Karen Morano(Children's Oncology Group)
Cited by 0
Related Papers
The Multimodal Brain Tumor Image Segmentation Benchmark (BRATS)
|IEEE Transactions on Medical Imaging|2014|6.7k
The Immune Landscape of Cancer
|Immunity|2018|6.3k
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
|CA A Cancer Journal for Clinicians|2007|2.6k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k
Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|1990|1.4k